• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TCGF III/P40由未成熟的鼠源CD4 + T细胞产生,但不是一种通用的T细胞生长因子。

TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor.

作者信息

Schmitt E, Van Brandwijk R, Van Snick J, Siebold B, Rüde E

机构信息

Institut für Immunologie der Johannes Gutenberg Universität, Mainz, FRG.

出版信息

Eur J Immunol. 1989 Nov;19(11):2167-70. doi: 10.1002/eji.1830191130.

DOI:10.1002/eji.1830191130
PMID:2574683
Abstract

Several antigen-specific T cell lines were found to secrete a lymphokine upon activation by antigen or lectin that was provisionally termed T cell growth factor III (TCGF III) because it induced the proliferation of a CD4+ T cell clone independently from IL2 and IL4. Amino acid sequence analysis (and the functional properties of TCGF III) revealed that TCGF III was identical with a recently identified lymphokine termed P40. TCGF III/P40 was not only produced by long-term cultured T cell lines but also upon stimulation of freshly isolated Mlsa-reactive T cells. In addition, naive CD4+ T cells secreted TCGF III/P40 upon activation by lectin or allo-major histocompatibility complex structures. However, in spite of its growth-promoting activity for a CD4+ T cell clone this lymphokine does not appear to function as a general growth factor for T cells.

摘要

发现几种抗原特异性T细胞系在被抗原或凝集素激活后会分泌一种淋巴因子,该淋巴因子因能独立于白细胞介素2(IL2)和白细胞介素4(IL4)诱导CD4 + T细胞克隆增殖,故而被暂时命名为T细胞生长因子III(TCGF III)。氨基酸序列分析(以及TCGF III的功能特性)表明,TCGF III与最近鉴定出的一种名为P40的淋巴因子相同。TCGF III / P40不仅由长期培养的T细胞系产生,新鲜分离的Mlsa反应性T细胞受到刺激时也会产生。此外,幼稚CD4 + T细胞在被凝集素或同种异体主要组织相容性复合体结构激活后会分泌TCGF III / P40。然而,尽管这种淋巴因子对CD4 + T细胞克隆具有促生长活性,但它似乎并非T细胞的通用生长因子。

相似文献

1
TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor.TCGF III/P40由未成熟的鼠源CD4 + T细胞产生,但不是一种通用的T细胞生长因子。
Eur J Immunol. 1989 Nov;19(11):2167-70. doi: 10.1002/eji.1830191130.
2
Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).粒细胞-巨噬细胞集落刺激因子(GM-CSF)诱导的白细胞介素2/白细胞介素4依赖性T细胞系的生长
J Immunol. 1987 Jun 15;138(12):4288-92.
3
Cognate interactions between helper T cells and B cells. I. Cloning and helper activity of a lymphokine-dependent helper T cell clone (Th-3).辅助性T细胞与B细胞之间的同源相互作用。I. 一种淋巴因子依赖性辅助性T细胞克隆(Th-3)的克隆及辅助活性
J Mol Cell Immunol. 1989;4(3):161-73; discussion 173-5.
4
IL-10, a novel growth cofactor for mature and immature T cells.白细胞介素-10,一种成熟和未成熟T细胞的新型生长辅助因子。
J Immunol. 1990 Dec 15;145(12):4167-73.
5
Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.不依赖白细胞介素2的T细胞自分泌生长:鉴定白细胞介素4(IL-4,BSF-1)为克隆的抗原特异性辅助性T细胞的自分泌生长因子。
J Immunol. 1987 Jun 15;138(12):4280-7.
6
Allo-Ia reactive murine T-cell lines. II. Mechanisms of clonal expansion of T cells explored by use of the allo-Ia reactive T cell clones.同种异体Ia反应性小鼠T细胞系。II. 利用同种异体Ia反应性T细胞克隆探索T细胞克隆扩增的机制。
J Immunol. 1983 Jul;131(1):37-44.
7
Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV).人类正常T细胞和白血病T细胞的生长:T细胞生长因子(TCGF)及一类新型RNA肿瘤病毒(HTLV)的分离
Blood Cells. 1981;7(2):313-29.
8
Disparate functional properties of two interleukin 1-responsive Ly-1+2- T cell clones: distinction of T cell growth factor and T cell-replacing factor activities.两个白细胞介素1反应性Ly-1+2-T细胞克隆的不同功能特性:T细胞生长因子和T细胞替代因子活性的区分
J Immunol. 1983 Apr;130(4):1743-8.
9
Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production.人T细胞白血病/淋巴瘤病毒感染的抗原特异性T细胞克隆:无差别辅助功能和淋巴因子产生。
J Immunol. 1985 Jun;134(6):4237-43.
10
Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.移植物抗宿主反应中活化的分泌淋巴因子的CD4 +和CD8 + T细胞的频率分析。
J Immunol. 1990 Oct 1;145(7):2167-76.

引用本文的文献

1
Regulatory role of T helper 9/interleukin-9: Transplantation view.辅助性T细胞9/白细胞介素-9的调节作用:移植视角
Heliyon. 2024 Feb 15;10(4):e26359. doi: 10.1016/j.heliyon.2024.e26359. eCollection 2024 Feb 29.
2
The application of Interleukin-2 family cytokines in tumor immunotherapy research.白细胞介素-2 家族细胞因子在肿瘤免疫治疗研究中的应用。
Front Immunol. 2023 Mar 2;14:1090311. doi: 10.3389/fimmu.2023.1090311. eCollection 2023.
3
First Characterization of Chicken Interleukin-9.鸡白细胞介素-9 的首次特征描述。
Front Immunol. 2022 Jun 20;13:889991. doi: 10.3389/fimmu.2022.889991. eCollection 2022.
4
and Single-Nucleotide Variants and Serum Levels in Age-Related Macular Degeneration in the Caucasian Population.并探讨了高加索人群年龄相关性黄斑变性中单核苷酸变异和血清水平。
Mediators Inflamm. 2021 Apr 12;2021:6622934. doi: 10.1155/2021/6622934. eCollection 2021.
5
Interaction between regulatory T cells and mast cells via IL-9 and TGF-β production.调节性T细胞与肥大细胞之间通过白细胞介素-9和转化生长因子-β的产生进行相互作用。
Oncol Lett. 2020 Dec;20(6):360. doi: 10.3892/ol.2020.12224. Epub 2020 Oct 14.
6
IL-9-producing T cells: potential players in allergy and cancer.产生白细胞介素-9 的 T 细胞:过敏与癌症的潜在参与者。
Nat Rev Immunol. 2021 Jan;21(1):37-48. doi: 10.1038/s41577-020-0396-0. Epub 2020 Aug 12.
7
The dichotomous function of interleukin-9 in cancer diseases.白细胞介素-9 在癌症疾病中的双重功能。
J Mol Med (Berl). 2019 Oct;97(10):1377-1383. doi: 10.1007/s00109-019-01826-5. Epub 2019 Aug 8.
8
Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity.组 2 固有淋巴细胞 (ILC2):2 型免疫与寄生虫免疫。
Int J Mol Sci. 2019 May 8;20(9):2276. doi: 10.3390/ijms20092276.
9
An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis.白细胞介素-9:从其细胞来源和信号转导到在免疫发病机制中的作用的最新进展。
Int J Mol Sci. 2019 Apr 29;20(9):2113. doi: 10.3390/ijms20092113.
10
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines.用常见的γ链细胞因子为癌症免疫疗法提供燃料。
Front Immunol. 2019 Feb 20;10:263. doi: 10.3389/fimmu.2019.00263. eCollection 2019.